Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Some drugs used to treat immune conditions may cause different types of hair loss.

Promising cancer treatments were found, but the manufacturer closed.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Alopecia areata is linked to autoimmune antibodies.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Activating a bitter taste receptor in hair follicles can stop hair growth by increasing a specific growth factor.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Graves' disease is a common cause of hyperthyroidism, mainly in women, treated with medication, iodine, or surgery, with varying outcomes.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.